Noubar Afeyan, a director at Moderna, has executed a sale of company stock valued at $433,878. This transaction was reported in a filing with the U.S. Securities and Exchange Commission. The sale is part of Afeyan's ongoing financial management and does not indicate any changes in his role or responsibilities within the company.
Related Articles
Don't miss out on breaking stories and in-depth articles.